Vertex Pharmaceuticals Inc. - Company & Market Research Reports

Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative new medicines. Founded in 1989 in Cambridge, MA, Vertex has research and development sites and commercial offices around the world in the United States, Canada, Europe and Australia. In May 2011, the U.S. Food and Drug Administration (FDA) approved Vertex’s first medicine, a treatment for hepatitis C. In 2012, Vertex received approval for our medicine for cystic fibrosis in the U.S., Europe and Canada. Vertex received Australian approval of our medicine for cystic fibrosis in 2013.

From
From
From
From
From
From
From
Hepatitis C - Pipeline Review, H2 2018 - Product Thumbnail Image

Hepatitis C - Pipeline Review, H2 2018

  • Drug Pipelines
  • 399 Pages
From
Hepatitis C - Pipeline Review, H1 2018 - Product Thumbnail Image

Hepatitis C - Pipeline Review, H1 2018

  • Drug Pipelines
  • 431 Pages
From
From
From
From
From
Loading Indicator
adroll